Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 1.21 Vs. IBES Estimate USD 1
10/05/2024 11:50
May 10 (Reuters) - ANI Pharmaceuticals Q1 revenue USD 137.43 million vs. IBES estimate USD 126 million. * Q1 net income USD 17.8 million * Q1 operating expenses USD 117.1 million * outlook FY adjusted EBITDA USD 135-145 million * outlook FY adjusted EPS USD 4.26-4.67
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma